The pandemic increase in beta-lactamase-resistant penicillins and of the above-mentioned broad-spectrum antibiotics may indicate an increase in nosocomial infections associated with the longer stay of critically ill COVID-19-patients and the use of immunosuppressive agents such as corticosteroids recommended in COVID-19 treatment guidelines [11,14,30,49]. The gene discussed is LACTB; the disease is COVID-19.